Raymond James Financial’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$112K Buy
2025
Q1
$58.1K Buy
2024
Q4
$75.6K Buy